Oscar U. Scremin

Oscar U. Scremin

Auto-generated profile, based on publicly available information

Oscar U. Scremin

Greater Los Angeles VA Healthcare System, United States; David Geffen School of Medicine at UCLA, Department of Physiology, United States

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2003 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PDF file
OSOscar U. Scremin
Oscar U. Scremin
TSTsung-Ming Shih
Tsung-Ming Shih
LHLy Huynh
Ly Huynh
MRMargareth Roch
Margareth Roch
RBRuth Booth
Ruth Booth
DJDonald J. Jenden
Donald J. Jenden
We tested the hypothesis that pyridostigmine bromide (PB) intake and/or low-level sarin exposure, suggested by some as causes of the symptoms experienced by Persian Gulf War veterans, induce neurobehavioral dysfunction that outlasts their effects on cholinesterase. Adult male Sprague-Dawley rats were treated during 3 weeks with s.c. saline, PB in drinking water (80 mg/l), sarin (62.5 μg/kg; 0.5× LD50, three times/week s.c.), or PB in drinking water + sarin. Animals were tested for passive avoidance, nociceptive threshold, acoustic startle, and open field activity 2, 4, or 16 weeks after treatment. Two weeks after sarin, acoustic startle was enhanced, whereas distance explored in the open field decreased. These effects were absent with PB + sarin or PB by itself. No effect on any variable was found at 4 weeks, whereas at 16 weeks sarin induced a decrease and PB + sarin induced an increase in habituation in the open field test. Nociceptive threshold was elevated in the PB + sarin group at 16 weeks. No effect of treatment on passive avoidance was noted in any group. Brain regional acetylcholinesterase and cholineacetyltransferase activities were not affected at any time after treatment, but muscarinic receptors were down-regulated in hippocampus, caudate putamen, and mesencephalon in the sarin group at 2 weeks. In conclusion, this study gives further support to the use of PB against nerve agent poisoning and does not support the hypothesis that delayed symptoms experienced by Persian Gulf War veterans could be due to PB, alone or in association with low-level sarin exposure.

1 December 2014 in NeuroToxicology
Verified
Journal Article
Closed access
MMMariel Muller
Mariel Muller
LHLeonardo Hess
Leonardo Hess
ATAgostina Tardivo
Agostina Tardivo
RLRafael Lajmanovich
Rafael Lajmanovich
AAAndres Attademo
Andres Attademo
OSOscar Scremin
Oscar Scremin

1 September 2000 in Hypertension
Verified
Journal Article
Closed access
PDF file
MMMartín L. Marro
Martín L. Marro
OSOscar U. Scremin
Oscar U. Scremin
MJMaria Concetta Jordan
Maria Concetta Jordan
LHLy Huynh
Ly Huynh
FPFabiola Porro
Fabiola Porro
AMAndrés Fernando Muro
Andrés Fernando Muro
Abstract —Polymorphic variants of the cytoskeletal protein adducin have been associated with hypertension in humans and rats. However, the direct role of this protein in modulating arterial blood pressure has never been demonstrated. To assess the effect of β-adducin on blood pressure, a β-adducin–deficient mouse strain (−/−) was studied and compared with wild-type controls (+/+). Aortic blood pressure was measured in nonanesthetized, freely moving animals with the use of telemetry implants. It is important to note that these mice have at least 98% of C57Bl/6 genetic background, with the only difference from wild-type animals being the β-adducin mutation. We found statistically significant higher levels of systolic blood pressure (mm Hg) (mean±SE values: −/−: 126.94±1.14, n=5; +/+: 108.06±2.34, n=6; P ≤0.0001), diastolic blood pressure (−/−: 83.54±1.07; +/+: 74.87±2.23; P ≤0.005), and pulse blood pressure (−/−: 43.32±1.10; +/+: 33.19±1.96; P ≤0.001) in β-adducin–deficient mice. Western blot analysis showed that as a result of the introduced genetic modification, β-adducin was not present in heart protein extracts from −/− mice. Consequently, this deficiency produced a sharp decrease of α-adducin and a lesser reduction in γ-adducin levels. However, we found neither cardiac remodeling nor modification of the heart function in these animals. This is the first report showing direct evidence that hypertension is triggered by a mutation in the adducin gene family.

8 December 2006 in Brain Research
Verified
Journal Article
Closed access
OSOscar U. Scremin
Oscar U. Scremin
MLMingen Grace Li
Mingen Grace Li
MRMargareth Roch
Margareth Roch
RBRuth Booth
Ruth Booth
DJDonald J. Jenden
Donald J. Jenden

1 April 1999 in Brain Research
Verified
Journal Article
Closed access
OSOscar U Scremin
Oscar U Scremin
DHDaniel P Holschneider
Daniel P Holschneider
KCKevin Chen
Kevin Chen
MLMingen G Li
Mingen G Li
JSJean C Shih
Jean C Shih

1 August 2015 in Neuroscience
Verified
Journal Article
Closed access
OSO.U. Scremin
O.U. Scremin
MRM. Roch
M. Roch
KNK.M. Norman
K.M. Norman
SDS. Djazayeri
S. Djazayeri
YLY.-Y. Liu
Y.-Y. Liu